Clinical Trial Update: ctDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)

View source ↗

Summary

A completed clinical study (Clear-HPVca) evaluated ctDNA liquid biopsy for early assessment of residual disease in HPV-positive oropharyngeal squamous cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-positive Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: HPV Positive Oropharyngeal Squamous Cell Carcinoma | Status: COMPLETED